Philadelphia Eagles quarterback Jalen Hurts is out Sunday against the Carolina Panthers after a follow-up ultrasound showed movement in a superficial calf blood clot, the team said.
The Eagles put their franchise quarterback on the sideline while doctors map out treatment, a move the club framed as putting health ahead of the Week 6 matchup. Backup Tanner McKee is in line to start.
OutKick reported that Hurts had been receiving treatment for nearly a week after telling trainers he was cleated in the October 4 game against the Los Angeles Rams. What began as a delayed calf complaint turned into a clotting issue the team monitored through a London trip and a full week of practice.
Team doctors first cleared him to play abroad. A later scan changed the plan.
The Eagles laid out a detailed medical timeline in a Thursday statement. Hurts did not seek help the moment the Rams game ended. He practiced in full the following Wednesday and Thursday before finally walking into the training room.
The club said:
"On Thursday, October 8th, Jalen visited the training room after practice requesting treatment for his calf. He informed the medical staff he had been cleated during the Rams game on October 4th. This was his first treatment session for the calf injury following the game, after having practiced in full both Wednesday and Thursday. On Friday, Jalen received treatment, practiced in full, and was added to the practice report."
That gap between the hit and the first treatment session is now part of the public record. Players often gut through pain. Blood clots do not care about toughness.
Serious medical scares can arrive without warning, much like the sudden crisis that left a victim rushed to hospital after a violent attack in another recent case.
After the team flew to London for its international game, staff ordered an ultrasound out of caution following the flight and walkthrough. The scan found a superficial blood clot in the calf.
London doctors reviewed the images and decided activity and mobility mattered. They cleared Hurts to play and asked for another ultrasound within 72 hours of the game and the return flight to Philadelphia. He played without limitation that Sunday against the Jacksonville Jaguars.
The Eagles stated:
"Out of an abundance of caution, an ultrasound was performed on Saturday following the team’s flight to London and walkthrough. The ultrasound revealed a superficial blood clot. Our medical staff and doctors in London reviewed the results and concluded that activity and mobility were important and that Jalen could safely play. Doctors recommended a follow-up ultrasound within 72 hours of the game and the return flight to Philadelphia."
He took treatment Monday and Tuesday, then practiced in full Wednesday. The club said it stayed in contact with the NFL league office the entire stretch.
Athletes and public figures alike have faced abrupt injury detours this year, including when Kai Trump undergoes wrist surgery that disrupted a freshman season.
The follow-up ultrasound Wednesday night delivered the change. It showed movement in the small blood clot. That finding ended any plan for Hurts to face Carolina.
Breitbart noted the same core sequence: Saturday discovery, prior clearance to play, then the Wednesday movement that pulled him from the Panthers game while treatment is sorted out.
The Eagles closed their statement this way:
"On Wednesday night, a follow-up ultrasound revealed movement in the small blood clot. Jalen will be out for Sunday’s game vs. the Panthers as we determine the appropriate course of treatment. His health and safety are our highest priority."
Superficial clots are not the deepest vein threats, yet they still demand respect. Clots can block flow, travel, and in worst cases lead to pulmonary embolism, stroke, heart attack, tissue damage, or death. The team’s public line is simple: health first, game second.
Independent medical voices have started sketching possible calendars. The New York Post spoke with physicians about monitoring, bleeding risk in a contact sport, and how oral anticoagulants can stretch recovery.
Dr. Ryan Schreiter gave a blunt range:
"I think this is going to be the downer... it’s usually 45 days to potentially three months on oral anticoagulants [blood thinners] and that is to make sure that that blood clot goes away."
That window is not official team policy. It is expert context for what “appropriate course of treatment” can mean when blood thinners and football pads share the same body. Bleeding risk rises when a player on thinners takes hits. Clubs and players weigh that every time.
Sudden harm forcing emergency care has marked other recent headlines, from a deadly Times Square knife attack to other abrupt medical crises that leave little room for delay.
Tanner McKee, a third-year veteran, is the backup now slotted to start against the Panthers. He has started two NFL games in his career. Philadelphia won one and lost one.
After Carolina, the Eagles draw the Dallas Cowboys, Washington Commanders, and New York Giants in a row. That is three division games stacked right after a forced quarterback change. Depth charts stop being theoretical when the starter’s calf becomes a clotting file.
How long Hurts stays out remains open. The team has not published a return date. It has not named a drug regimen. It has only said the next step is determining treatment while keeping his safety at the top of the list.
Fans want wins. Front offices want October and November intact. None of that outranks a clot that already moved once under medical watch. Rushing a quarterback back to protect a seeding race is how organizations turn a manageable problem into a catastrophe.
Protect the player first, trust the scans, and earn the wins with whoever can safely take the snaps, that is the only order that holds up when the ultrasound results refuse to stay still.